Skip to content
S6733Senate2021-2022 SessionSame asA3697

Require Insurance for Narcan

Official title

“Requires health insurers to provide coverage for opioid antagonists and devices”

Sponsor Pete HarckhamSD-40Affects Finance
Status
In Senate Committee
Insurance
Impact
7/10
Significant
Passage
0%

Bill progress

Step 2 of 7

In committee · Insurance

What's happening

This bill requires health insurers in New York to cover at least one opioid antagonist and device, such as naloxone.

Why it matters

  1. Expands access to life-saving overdose medications. by ensuring that all insurance plans covering prescriptions must include at least one FDA-approved opioid antagonist, such as naloxone, which can rapidly reverse opioid overdoses.

  2. Allows coverage for third-party prescriptions. , meaning insurance must also cover opioid antagonists obtained via standing orders or collaborative practice agreements—enabling family, friends, or organizations to obtain these medications for use on others, not just the insured individual.

  3. Balances access with cost controls. , permitting insurers to require prior authorization for non-generic (brand-name) opioid antagonists and to apply existing deductibles and co-insurance, which could impact out-of-pocket costs and choice of products.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Require Insurance for Narcan

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Pete Harckham

Senator · Senate District 40

Chair, Alcoholism And Substance Abuse

No co-sponsors yet.

History

  1. Referred to insurance
  2. Referred to insurance

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A3697Assembly

Require Insurance for Overdose Antidotes

In Assembly Committee · Insurance · Sponsor Linda Rosenthal

Impact 7 · Significant0% to pass

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

6733

2021-2022 Regular Sessions

IN SENATE

May 13, 2021

Introduced by Sen. HARCKHAM -- read twice and ordered printed, and when printed to be committed to the Committee on Insurance

AN ACT to amend the insurance law, in relation to requiring health insurers to provide coverage for opioid antagonists and devices

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subsection (i) of section 3216 of the insurance law is amended by adding a new paragraph 36 to read as follows:

(36) (A) (i) Every policy which provides coverage for prescription drugs shall include coverage for at least one opioid antagonist and device. Prior authorization may be required for non-generic forms of opioid antagonists and devices.

(ii) As used in this paragraph "opioid antagonist and device" means a drug approved by the Food and Drug Administration that, when administered, negates or neutralizes in whole or in part the pharmacological effects of an opioid in the body. "Opioid antagonist" shall be limited to naloxone and other medications approved by the department of health for such purpose.

(B) The coverage mandated by this paragraph shall include opioid antagonists prescribed or dispensed via standing order or collaborative practice agreement intended for use on patients other than the insured.

(C) Coverage provided under this paragraph may be subject to annual deductibles and co-insurance as deemed appropriate by the superintendent and that are consistent with those imposed on other benefits within a given policy.

§ 2. Subsection (l) of section 3221 of the insurance law is amended by adding a new paragraph 7-b to read as follows:

(7-b) (A) (i) Every policy which provides coverage for prescription drugs shall include coverage for at least one opioid antagonist and device. Prior authorization may be required for non-generic forms of opioid antagonists and devices.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD00880-01-1

S. 6733 2

(ii) As used in this paragraph "opioid antagonist and device" means a drug approved by the Food and Drug Administration that, when administered, negates or neutralizes in whole or in part the pharmacological effects of an opioid in the body. "Opioid antagonist" shall be limited to naloxone and other medications approved by the department of health for such purpose.

(B) The coverage mandated by this paragraph shall include opioid antagonists prescribed or dispensed via standing order or collaborative practice agreement intended for use on patients other than the insured.

(C) Coverage provided under this paragraph may be subject to annual deductibles and co-insurance as deemed appropriate by the superintendent and that are consistent with those imposed on other benefits within a given policy.

§ 3. Section 4303 of the insurance law is amended by adding a new subsection (ss) to read as follows:

(ss) (1) (A) Every policy which provides coverage for prescription drugs shall include coverage for at least one opioid antagonist and device. Prior authorization may be required for non-generic forms of opioid antagonists and devices.

(B) As used in this subsection "opioid antagonist and device" means a drug approved by the Food and Drug Administration that, when administered, negates or neutralizes in whole or in part the pharmacological effects of an opioid in the body. "Opioid antagonist" shall be limited to naloxone and other medications approved by the department of health for such purpose.

(2) Coverage provided under this subsection may be subject to annual deductibles and co-insurance as deemed appropriate by the superintendent and that are consistent with those imposed on other benefits within a given policy.

§ 4. This act shall take effect on the thirtieth day after it shall have become a law.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the insurance law, in relation to requiring health insurers to provide coverage for opioid antagonists and devices

Purpose

This bill requires health insurers to provide coverage for opioid antag- onists and devices.

Summary of specific provisions

Section one amends section 3216 of the insurance law by adding a new paragraph 35.

Section two amends subsection 1 of section 3221 of the insurance law by adding a new paragraph 7-c. Section three amends section 4303 of the insurance law is amended by adding a new subsection ss. Section four sets forth the effective date.

Justification

The rate of opioid overdose deaths in New York State rose 32% from 2015 to 2016, and there is little to indicate that the severity of that trend has abated. The most immediate concern with addressing this public health crisis is saving lives, and to do that we need to ensure that any New Yorker who wants to equip themselves with a lifesaving opioid antag- onist, either for themselves or for someone else, can do that. Currently though, under threat of audit from insurance companies, pharmacies are often only selling opioid antagonists to individuals who are purchasing an opioid antagonist for personal use. The deadly consequence of this crackdown is that New Yorkers are often prevented from saving the life of another.

This legislation will require that every policy that provides coverage for prescription drugs shall include coverage for at least one opioid antagonist and device. Critically, the coverage must include opioid antagonists intended for use on patients other than the insured. This bill empowers those seeking to be proactive in protecting the life of someone they believe to be at risk, and helps expand New York State's overdose prevention network.

Legislative history

2019-20: A.2773 Referred to Insurance

2017-18: A.10622 - Referred to Health; S.8891 - Referred to Insurance

Fiscal implications

Undetermined.

Effective date

This act shall take effect immediately after it shall have become a law.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.